Ixazomib-Lenalidomide-Dexamethasone (IRd) Consolidation Following Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Large Multi-Center Phase II Trial

Ravi Vij; Nitya Nathwani; Thomas G. Martin; Mark A. Fiala; Abhinav Deol; Francis K. Buadi; Jonathan L Kaufman; Craig C Hofmeister; Tara Gregory; Jesus G. Berdeja; Ajai Chari; Ashley E. Rosko

doi:10.1182/BLOOD-2018-99-109920

Ixazomib-Lenalidomide-Dexamethasone (IRd) Consolidation Following Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Large Multi-Center Phase II Trial

Ravi Vij
, Nitya Nathwani
, Thomas G. Martin
, Mark A. Fiala
, Abhinav Deol
, Francis K. Buadi
, Jonathan L Kaufman
, Craig C Hofmeister
, Tara Gregory
, Jesus G. Berdeja
, Ajai Chari
, Ashley E. Rosko

Washington University in St. Louis
City of Hope National Medical Center
University of California, San Francisco
Wayne State University
Mayo Clinic
Emory University
Colorado Blood Cancer Institute, Denver, CO
Sarah Cannon Research Institute
Icahn School of Medicine at Mount Sinai
Ohio State University

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Blood
Volume	132
DOIs	https://doi.org/10.1182/BLOOD-2018-99-109920
State	Published - Nov 29 2018
Externally published	Yes

Disciplines

Medicine and Health Sciences
Family Medicine

Access to Document

10.1182/BLOOD-2018-99-109920License: Unspecified

Cite this

Vij, R., Nathwani, N., Martin, T. G., Fiala, M. A., Deol, A., Buadi, F. K., Kaufman, J. L., Hofmeister, C. C., Gregory, T., Berdeja, J. G., Chari, A., & Rosko, A. E. (2018). Ixazomib-Lenalidomide-Dexamethasone (IRd) Consolidation Following Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Large Multi-Center Phase II Trial. Blood, 132. https://doi.org/10.1182/BLOOD-2018-99-109920

Vij, R, Nathwani, N, Martin, TG, Fiala, MA, Deol, A, Buadi, FK, Kaufman, JL, Hofmeister, CC, Gregory, T, Berdeja, JG, Chari, A & Rosko, AE 2018, 'Ixazomib-Lenalidomide-Dexamethasone (IRd) Consolidation Following Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Large Multi-Center Phase II Trial', Blood, vol. 132. https://doi.org/10.1182/BLOOD-2018-99-109920

@article{68fdcc1bf74c497398e6e0f7559b61fa,

title = "Ixazomib-Lenalidomide-Dexamethasone (IRd) Consolidation Following Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Large Multi-Center Phase II Trial",

author = "Ravi Vij and Nitya Nathwani and Martin, \{Thomas G.\} and Fiala, \{Mark A.\} and Abhinav Deol and Buadi, \{Francis K.\} and Kaufman, \{Jonathan L\} and Hofmeister, \{Craig C\} and Tara Gregory and Berdeja, \{Jesus G.\} and Ajai Chari and Rosko, \{Ashley E.\}",

note = "731. Clinical Autologous Transplantation: Results: Multiple Myeloma: Upfront Autologous Transplantation | Ravi Vij, Nitya Nathwani, Thomas G. Martin, Mark A. Fiala, Abhinav Deol, Francis K. Buadi, Jonathan L Kaufman, Craig C Hofmeister, Tara Gregory, Jesus G. Berdeja, Ajai Chari, Ashley E.",

year = "2018",

month = nov,

day = "29",

doi = "10.1182/BLOOD-2018-99-109920",

language = "American English",

volume = "132",

journal = "Blood",

publisher = "American Society of Hematology",

}

TY - JOUR

T1 - Ixazomib-Lenalidomide-Dexamethasone (IRd) Consolidation Following Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Large Multi-Center Phase II Trial

AU - Vij, Ravi

AU - Nathwani, Nitya

AU - Martin, Thomas G.

AU - Fiala, Mark A.

AU - Deol, Abhinav

AU - Buadi, Francis K.

AU - Kaufman, Jonathan L

AU - Hofmeister, Craig C

AU - Gregory, Tara

AU - Berdeja, Jesus G.

AU - Chari, Ajai

AU - Rosko, Ashley E.

N1 - 731. Clinical Autologous Transplantation: Results: Multiple Myeloma: Upfront Autologous Transplantation | Ravi Vij, Nitya Nathwani, Thomas G. Martin, Mark A. Fiala, Abhinav Deol, Francis K. Buadi, Jonathan L Kaufman, Craig C Hofmeister, Tara Gregory, Jesus G. Berdeja, Ajai Chari, Ashley E.

PY - 2018/11/29

Y1 - 2018/11/29

UR - https://ashpublications.org/blood/article/132/Supplement%201/123/262596/Ixazomib-Lenalidomide-Dexamethasone-IRd

U2 - 10.1182/BLOOD-2018-99-109920

DO - 10.1182/BLOOD-2018-99-109920

M3 - Article

VL - 132

JO - Blood

JF - Blood

ER -

Ixazomib-Lenalidomide-Dexamethasone (IRd) Consolidation Following Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Large Multi-Center Phase II Trial

Disciplines

Access to Document

Other files and links

Cite this